These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10618306)

  • 1. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women.
    Roest M; van der Schouw YT; Banga JD; Tempelman MJ; de Groot PG; Sixma JJ; Grobbee DE
    Circulation; 2000 Jan 4-11; 101(1):67-70. PubMed ID: 10618306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.
    Hoekstra T; Geleijnse JM; Kluft C; Giltay EJ; Kok FJ; Schouten EG
    Stroke; 2003 Dec; 34(12):2822-8. PubMed ID: 14605330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction.
    Sibbing D; von Beckerath O; von Beckerath N; Koch W; Mehilli J; Schwaiger M; Schömig A; Kastrati A
    Blood Coagul Fibrinolysis; 2005 Oct; 16(7):511-5. PubMed ID: 16175011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association of the plasminogen activator inhibitor-1 4G/5G promoter polymorphism with cardiovascular disease in the elderly.
    Crainich P; Jenny NS; Tang Z; Arnold AM; Kuller LH; Manolio T; Sharrett AR; Tracy RP
    J Thromb Haemost; 2003 Aug; 1(8):1799-804. PubMed ID: 12911596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm.
    Jones K; Powell J; Brown L; Greenhalgh R; Jormsjö S; Eriksson P
    Eur J Vasc Endovasc Surg; 2002 May; 23(5):421-5. PubMed ID: 12027469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease.
    Catto AJ; Carter AM; Stickland M; Bamford JM; Davies JA; Grant PJ
    Thromb Haemost; 1997 Apr; 77(4):730-4. PubMed ID: 9134651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
    Ye S; Green FR; Scarabin PY; Nicaud V; Bara L; Dawson SJ; Humphries SE; Evans A; Luc G; Cambou JP
    Thromb Haemost; 1995 Sep; 74(3):837-41. PubMed ID: 8571307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.
    Ridker PM; Hennekens CH; Lindpaintner K; Stampfer MJ; Miletich JP
    Circulation; 1997 Jan; 95(1):59-62. PubMed ID: 8994417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women.
    Hindorff LA; Schwartz SM; Siscovick DS; Psaty BM; Longstreth WT; Reiner AP
    J Cardiovasc Risk; 2002 Apr; 9(2):131-7. PubMed ID: 12006921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.
    Ding J; Nicklas BJ; Fallin MD; de Rekeneire N; Kritchevsky SB; Pahor M; Rodondi N; Li R; Zmuda JM; Harris TB
    Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China.
    Zhan M; Zhou Y; Han Z
    Chin Med J (Engl); 2003 Nov; 116(11):1707-10. PubMed ID: 14642142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
    Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
    Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease.
    Onalan O; Balta G; Oto A; Kabakci G; Tokgozoglu L; Aytemir K; Altay C; Gurgey A; Nazli N
    J Thromb Thrombolysis; 2008 Dec; 26(3):211-7. PubMed ID: 17721742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1.
    Bergheanu SC; Pons D; Jukema JW; van der Hoeven BL; Liem SS; Vandenbroucke JP; Rosendaal FR; le Cessie S; Schalij MJ; van der Bom JG
    Chronobiol Int; 2009 May; 26(4):637-52. PubMed ID: 19444746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients.
    Wang AY; Poon P; Lai FM; Yu L; Choi PC; Lui SF; Li PK
    Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
    Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
    Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.
    Boncoraglio GB; Bodini A; Brambilla C; Carriero MR; Ciusani E; Parati EA
    Cerebrovasc Dis; 2006; 22(2-3):191-5. PubMed ID: 16735791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.
    Iwai N; Shimoike H; Nakamura Y; Tamaki S; Kinoshita M
    Atherosclerosis; 1998 Jan; 136(1):109-14. PubMed ID: 9544737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.